The Birmingham News - al.com
The Associated Press
BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan. ...
BioCryst partner files to market flu drug in JapanBizjournals.com
BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in JapanReuters
Shionogi Seeks Approval to Sell Flu Drug in JapanBloomberg
Wall Street Journal -Trading Markets (press release)
all 126 news articles »
No comments:
Post a Comment